For the Inventor, By the Inventor

Enter assignee name

Framingham, MA, United States of America

Bpgbio, Inc.

USPTO Granted Patents = 11

EPO Patents = 6

Trademarks = 7

Forward Citations = 3

Loading Chart...

Loading Chart...

24 inventors (with patents filed for the assignee):

Niven Rajin Narain (9 out of 51 patents)

Rangaprasad Sarangarajan (6 out of 30 patents)

Viatcheslav R Akmaev (4 out of 13 patents)

4. Michael Andrew Kiebish (3 out of 6 patents)

5. John Patrick McCook (2 out of 25 patents)

6. Vijetha Vemulapalli (2 out of 3 patents)

7. Vivek K Vishnudas (2 out of 2 patents)

8. Joaquin J Jimenez (1 out of 14 patents)

9. Thomas Mitchell Gray (1 out of 4 patents)

10. Shiv Srivastava (1 out of 22 patents)

11. Wenfang Sybil Wu (1 out of 2 patents)

12. Shobha Ravipaty (1 out of 2 patents)

13. Tracey Friss (1 out of 2 patents)

14. Albert Dobi (1 out of 9 patents)

15. Min Du (1 out of 3 patents)

11 patents: Sort by Forward Citations

1. 12691081 - Methods for the treatment of cancer using coenzyme Q10 combination therapies (2026-07-28),

2. 12653776 - Methods of treatment of cancer by continuous infusion of coenzyme Q10 (2026-06-16),

3. 12626169 - Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data (2026-05-12),

4. 12616666 - Coenzyme Q10 formulations in the treatment and prevention of epidermolysis bullosa (2026-05-05),

5. 12437835 - Interrogatory cell-based assays and uses thereof (2025-10-07),

6. 12329726 - Biomarkers for efficacy of prophylactic treatments against stress-induced affective disorders (2025-06-17),

7. 12320812 - Markers for the diagnosis of biochemical recurrence in prostate cancer (2025-06-03),

8. 12303471 - Methods of treatment of temozolomide-resistant glioma using coenzyme Q10 (2025-05-20),

9. 12209285 - Methods for treatment of oncological disorders using an epimetabolic shifter (coenzyme Q10) (2025-01-28),

10. 11866487 - Filamin A binding proteins and uses thereof (2024-01-09),

11. 11734593 - Bayesian causal relationship network models for healthcare diagnosis and treatment based on patient data (2023-08-22),

Bpgbio, Inc. is a biotechnology company focused on developing innovative therapies for unmet medical needs. With a robust pipeline of product candidates, the company leverages advanced technologies in drug discovery and development. Bpgbio aims to address critical medical challenges in areas such as oncology and rare diseases, striving to improve patient outcomes through targeted treatment approaches. The company's scientific expertise is complemented by a commitment to collaboration with research institutions and healthcare providers, ensuring that their therapies are both effective and accessible.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

11 Patents

#22 in Framingham, MA

#1,660 in Massachusetts

#27,470 in US

#51,671 in the World

Framingham, MA, United States of America

Bpgbio, Inc.

Forward Citations = 3

24 inventors:

Niven Rajin Narain (9 out of 51 patents)

Rangaprasad Sarangarajan (6 out of 30 patents)

Viatcheslav R Akmaev (4 out of 13 patents)

4. Michael Andrew Kiebish (3 out of 6 patents)

5. John Patrick McCook (2 out of 25 patents)

Please report any incorrect information to [email protected]

Loading…